These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 19241626)

  • 1. ASHP statement on criteria for an intermediate category of drug products.
    American Society of Health-System Pharmacists
    Am J Health Syst Pharm; 2009 Mar; 66(5):502-5. PubMed ID: 19241626
    [No Abstract]   [Full Text] [Related]  

  • 2. ASHP Statement on the Role of Health-System Pharmacists in Public Health.
    American Society of Health-System Pharmacists
    Am J Health Syst Pharm; 2008 Mar; 65(5):462-7. PubMed ID: 18281740
    [No Abstract]   [Full Text] [Related]  

  • 3. ASHP statement on leadership as a professional obligation.
    Am J Health Syst Pharm; 2011 Dec; 68(23):2293-5. PubMed ID: 22201191
    [No Abstract]   [Full Text] [Related]  

  • 4. ASHP guidelines on home infusion pharmacy services.
    Petroff BJ; Filibeck D; Nowobilski-Vasilios A; Olsen RS; Rollins CJ; Johnson C
    Am J Health Syst Pharm; 2014 Feb; 71(4):325-41. PubMed ID: 24481158
    [No Abstract]   [Full Text] [Related]  

  • 5. Oh, the places they can go: response to APhA-ASHP report on concerns about accelerating expansion of pharmacy education.
    Teagarden RJ; Furgieule T
    J Am Pharm Assoc (2003); 2011; 51(3):327-8. PubMed ID: 21555282
    [No Abstract]   [Full Text] [Related]  

  • 6. Conundrums within a culture of safety.
    Rinehart JR
    Am J Health Syst Pharm; 2010 Jul; 67(14):1206-7. PubMed ID: 20592329
    [No Abstract]   [Full Text] [Related]  

  • 7. ASHP statement on the role of the medication safety leader.
    Developed through the ASHP Section of Inpatient Care Practitioners Section Advisory Group on Medication Safety and approved by the ASHP Council on Education and Workforce Development on February 21, 2012; by the ASHP Board of Directors on April 13, 2012;
    Am J Health Syst Pharm; 2013 Mar; 70(5):448-552. PubMed ID: 23413170
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravenous medications in long-term care: a wake-up call for pharmacists.
    Martin CM
    Consult Pharm; 2009 Sep; 24(9):663-8. PubMed ID: 19842782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient safety: a subject needed in pharmacy education.
    Martínez Sánchez Ade L
    Am J Pharm Educ; 2010 Apr; 74(3):52b. PubMed ID: 20498746
    [No Abstract]   [Full Text] [Related]  

  • 10. ASHP Guidelines on Pharmacy Services in Solid Organ Transplantation.
    Maldonado AQ; Hall RC; Pilch NA; Ensor CR; Anders S; Gilarde JA; Tichy EM
    Am J Health Syst Pharm; 2020 Jan; 77(3):222-232. PubMed ID: 31834928
    [No Abstract]   [Full Text] [Related]  

  • 11. Report of the APhA and APhA-ASP Houses of Delegates.
    Bzowyckyj A; Oestreich J; Kirk LM
    J Am Pharm Assoc (2003); 2015; 55(4):340, 342-4, 346-7. PubMed ID: 26161477
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of a professional organization in promoting and conducting research: the Lebanese Order of Pharmacists' experience.
    Hallit S; Sacre H; Salameh P
    Int J Pharm Pract; 2019 Jun; 27(3):330-331. PubMed ID: 31111986
    [No Abstract]   [Full Text] [Related]  

  • 13. Medication risk mitigation matrix: A pharmaceutical care opportunity for precision medication.
    Knowlton CH
    J Am Pharm Assoc (2003); 2015; 55(4):354-8. PubMed ID: 25820799
    [No Abstract]   [Full Text] [Related]  

  • 14. Need for greater continuity of care.
    Manasse HR; Menighan TE
    Am J Health Syst Pharm; 2011 Mar; 68(6):476, 478. PubMed ID: 21378293
    [No Abstract]   [Full Text] [Related]  

  • 15. ASHP guidelines on the pharmacy and therapeutics committee and the formulary system.
    Tyler LS; Cole SW; May JR; Millares M; Valentino MA; Vermeulen LC; Wilson AL;
    Am J Health Syst Pharm; 2008 Jul; 65(13):1272-83. PubMed ID: 18589893
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of the pharmaceutical case management program implemented in a private sector health plan.
    Witry MJ; Doucette WR; Gainer KL
    J Am Pharm Assoc (2003); 2011; 51(5):631-5. PubMed ID: 21896463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimising medication use during pregnancy: the potential role of pharmacists.
    George J
    Int J Pharm Pract; 2011 Apr; 19(2):81-3. PubMed ID: 21385238
    [No Abstract]   [Full Text] [Related]  

  • 18. Achieving recognition as patient-centered care providers: we are our own best advocates.
    Cooke RL; Lipowski E; Magness JW
    J Am Pharm Assoc (2003); 2013; 53(3):234, 236-8. PubMed ID: 23699671
    [No Abstract]   [Full Text] [Related]  

  • 19. ASHP statement on the pharmacist's role in medication reconciliation.
    Developed through the ASHP Council on Pharmacy Practice and approved by the ASHP Board of Directors on April 13, 2012, and by the ASHP House of Delegates on June 10, 2012
    Am J Health Syst Pharm; 2013 Mar; 70(5):453-6. PubMed ID: 23413171
    [No Abstract]   [Full Text] [Related]  

  • 20. Need for greater continuity of care.
    Manasse HR; Menighan TE
    J Am Pharm Assoc (2003); 2011; 51(2):134. PubMed ID: 21382800
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.